Stabilisation & Protection

In vitro study

Drug incorporation in hydrophobic lipid matrix Particle size: 40-50 µm Loading ratio: 35 % w/w Yield: 90 %

The technology ORALANCE® besides the micro incorporation properties of hydrophilic and mineral molecules, allows the formulation and stabilisation of hydrophobic molecules in aqueous phases. The technology can be applied to any oral drug delivery form (syrups, aqueous suspensions, powders, gel, pasty forms, capsules, lyophilics)

The ORALANCE® technology also allows gastro-resistant dry or liquid formulations, without modification of release properties.